Ailing Song is an experienced Clinical Development Leader with over 15 years in late-phase global clinical trials and regulatory submissions within the biopharma industry. Currently serving as the Director of Clinical Development at Gilead Sciences, Ailing leads cross-functional teams in designing and executing pivotal studies while ensuring compliance with regulatory standards. Ailing has directed NDA/BLA submissions and contributed significantly to portfolio strategy, presenting study results to regulators and scientific conferences. Ailing's educational background includes a Doctor of Philosophy in Pharmacology from the University of California, San Francisco, and a Bachelor of Science in Pharmacy from 上海中医药大学.
This person is not in the org chart
This person is not in any teams
This person is not in any offices